ATNM
Actinium Pharmaceuticals Inc
NYSE MKT: ATNM · HEALTHCARE · BIOTECHNOLOGY
$1.12
-4.70% today
Updated 2026-04-30
Market cap
$40.16M
P/E ratio
—
P/S ratio
446.22x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Actinium Pharmaceuticals Inc (ATNM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-40,274.00%
ROE
-167.00%
ROA
-35.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-18404.00 | — | — | — |
| 2007 | — | $-14800.00 | — | — | — |
| 2008 | — | $-31243.00 | — | — | — |
| 2009 | — | $-22331.00 | — | — | — |
| 2010 | — | $1674.00 | — | — | — |
| 2011 | — | $10289.00 | — | — | — |
| 2012 | — | $-8.36M | — | — | — |
| 2013 | — | $-10.77M | — | — | — |
| 2014 | $0.00 | $-24.69M | — | — | — |
| 2015 | $0.00 | $-21.02M | — | — | — |
| 2016 | $0.00 | $-24.32M | — | — | — |
| 2017 | $0.00 | $-26.60M | — | — | — |
| 2018 | $0.00 | $-23.65M | — | — | — |
| 2019 | $0.00 | $-21.90M | — | — | — |
| 2020 | $622000.00 | $-22.21M | -71.86% | -3,600.16% | -3,571.54% |
| 2021 | $1.14M | $-24.77M | 54.20% | -2,182.17% | -2,165.56% |
| 2022 | $1.03M | $-33.02M | 100.00% | -3,311.07% | -3,205.53% |
| 2023 | $81000.00 | $-48.82M | 100.00% | -64,098.77% | -60,269.14% |
| 2024 | $0.00 | $-38.24M | — | — | — |
| 2025 | $90000.00 | $-33.89M | 100.00% | -40,274.44% | -37,652.22% |